Selective enhancement of the tumour necrotic activity of TNF α with monoclonal antibody
- 1 June 1992
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 65 (6) , 852-856
- https://doi.org/10.1038/bjc.1992.180
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Antigenic structure of human tumour necrosis factor: Recognition of distinct regions of TNFα by different tumour cell receptorsMolecular Immunology, 1991
- Autoantibodies to cytokines - friends or foes?Immunology Today, 1990
- Molecular cloning and expression of the human 55 kd tumor necrosis factor receptorCell, 1990
- Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor.The Journal of Experimental Medicine, 1990
- Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins.The Journal of Experimental Medicine, 1989
- Antibody-mediated enhancement of hormone activityMolecular Immunology, 1989
- Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.Journal of Clinical Investigation, 1987
- Phase I study of recombinant human tumor necrosis factorCancer Chemotherapy and Pharmacology, 1987
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986
- Monoclonal antibodies to human growth hormone can distinguish between pituitary and genetically engineered formsMolecular Immunology, 1985